(BOLD) Audentes Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Audentes Therapeutics | (BOLD) share price targets
Complete technical analysis of Audentes Therapeutics (BOLD) by charts plus indicators, forecast predictions and share price targets for Audentes Therapeutics (BOLD)
Audentes Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Audentes Therapeutics is 86280
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Thu May 2025 | 1.17 | 1.20 | 1.23 | 1.13 | 1.646 times |
| 28 Wed May 2025 | 1.20 | 1.34 | 1.35 | 1.20 | 2.345 times |
| 27 Tue May 2025 | 1.30 | 1.58 | 1.58 | 1.22 | 4.01 times |
| 23 Fri May 2025 | 1.54 | 1.46 | 1.62 | 1.46 | 0.546 times |
| 22 Thu May 2025 | 1.56 | 1.66 | 1.66 | 1.53 | 0.292 times |
| 21 Wed May 2025 | 1.66 | 1.63 | 1.66 | 1.59 | 0.495 times |
| 20 Tue May 2025 | 1.66 | 1.71 | 1.71 | 1.61 | 0.26 times |
| 19 Mon May 2025 | 1.69 | 1.63 | 1.72 | 1.60 | 0.382 times |
| 16 Fri May 2025 | 1.65 | 1.69 | 1.69 | 1.61 | 0.316 times |
| 15 Thu May 2025 | 1.69 | 1.49 | 1.72 | 1.49 | 1.042 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 1.2, for a target of 1.4 or 1.53
Share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Target | 1.06 |
| Downside Target | 1.13 |
| Upside Target | 1.40 |
| Upside Target | 1.46 |
| Upside Target | 1.58 |
| Upside Target | 1.70 |
| Upside Target | 1.78 |
| Upside Target | 1.80 |
| Upside Target | 1.91 |
| Upside Target | 2.19 |
| Upside Target | 2.54 |
| Upside Target | 3.12 |
Intraday share price targets for Audentes Therapeutics (BOLD)
| Target Type | Value |
| Downside Intraday Target | 1.01 |
| Downside Intraday Target | 0.84 |
| Upside Intraday Target | 1.46 |
| Upside Intraday Target | 1.74 |
| Upside Intraday Target | 1.29 |
Weekly technical analysis of Audentes Therapeutics (BOLD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Thu May 2025 | 1.17 | 1.58 | 1.58 | 1.13 | 4.051 times |
| 23 Fri May 2025 | 1.54 | 1.63 | 1.72 | 1.46 | 0.858 times |
| 16 Fri May 2025 | 1.65 | 1.50 | 1.72 | 1.40 | 0.615 times |
| 09 Fri May 2025 | 1.44 | 1.50 | 1.70 | 1.42 | 1.105 times |
| 02 Fri May 2025 | 1.61 | 1.46 | 1.78 | 1.40 | 0.996 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Audentes Therapeutics (BOLD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Thu May 2025 | 1.17 | 1.78 | 1.78 | 1.13 | 1.005 times |
| 30 Wed Apr 2025 | 1.76 | 1.47 | 1.78 | 1.06 | 0.917 times |
| 31 Mon Mar 2025 | 1.51 | 1.88 | 1.91 | 1.43 | 1.374 times |
| 28 Fri Feb 2025 | 1.93 | 2.24 | 2.54 | 1.80 | 0.726 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Audentes Therapeutics (BOLD)
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.36 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Audentes Therapeutics ( (BOLD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Audentes Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.36 and Audentes Therapeutics (BOLD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics (BOLD) stock. Volume based technical analysis of Audentes Therapeutics (BOLD) stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.